Viktor Soukup
Charles University in Prague
CancerInternal medicineUrologyPathologyOncologymicroRNARetrospective cohort studyStage (cooking)CystectomyCystoscopyDiseaseUrinary bladderUrineProstate cancerBladder cancerGynecologyIn patientMedicineUrinary systemBiology
106Publications
17H-index
2,761Citations
Publications 107
Newest
#1Marko Babjuk (Charles University in Prague)H-Index: 31
#2Maximilian Burger (University of Regensburg)H-Index: 53
Last. A. Hugh MostafidH-Index: 9
view all 17 authors...
Abstract null null Context null The European Association of Urology (EAU) has released an updated version of the guidelines on non–muscle-invasive bladder cancer (NMIBC). null null null Objective null To present the 2021 EAU guidelines on NMIBC. null null null Evidence acquisition null A broad and comprehensive scoping exercise covering all areas of the NMIBC guidelines since the 2020 version was performed. Databases covered by the search included Medline, EMBASE, and the Cochrane Libraries. Pre...
Source
#1Francesca Pisano (University of Barcelona)H-Index: 12
#2P. GonteroH-Index: 5
Last. Anne J. Grotenhuis (Radboud University Nijmegen Medical Centre)H-Index: 15
view all 29 authors...
Resumen null null Introduccion y objetivos null Los objetivos de la reseccion transuretral (RTU) del tumor vesical son la reseccion completa de las lesiones y la realizacion de un diagnostico correcto con el objetivo de estadificar adecuadamente al paciente. Es bien sabido que la presencia de musculo detrusor en el especimen es un requisito previo para minimizar el riesgo de infraestadificacion. null La persistencia de enfermedad tras la reseccion de los tumores vesicales no es infrecuente, y es...
Source
#1Francesca Pisano (University of Barcelona)H-Index: 12
#2P. GonteroH-Index: 5
Last. Juan Palou (University of Barcelona)H-Index: 32
view all 29 authors...
Resumen Introduccion y objetivos Los objetivos de la reseccion transuretral (RTU) del tumor vesical son la reseccion completa de las lesiones y la realizacion de un diagnostico correcto con el objetivo de estadificar adecuadamente al paciente. Es bien sabido que la presencia de musculo detrusor en el especimen es un requisito previo para minimizar el riesgo de infraestadificacion. La persistencia de enfermedad tras la reseccion de los tumores vesicales no es infrecuente, y es la razon por la que...
Source
#1Bas W.G. van RhijnH-Index: 54
#2Anouk E. Hentschel (VU: VU University Amsterdam)H-Index: 5
Last. Shahrokh F. Shariat (Charles University in Prague)H-Index: 136
view all 61 authors...
Abstract Background In the current European Association of Urology (EAU) non–muscle-invasive bladder cancer (NMIBC) guideline, two classification systems for grade are advocated: WHO1973 and WHO2004/2016. Objective To compare the prognostic value of these WHO systems. Design, setting, and participants Individual patient data for 5145 primary Ta/T1 NMIBC patients from 17 centers were collected between 1990 and 2019. The median follow-up was 3.9 yr. Outcome measurements and statistical analysis Un...
Source
#1R. Sylvester (European Association of Urology)H-Index: 18
#2Oscar Rodríguez (Autonomous University of Barcelona)H-Index: 9
Last. Jose Rubio-BrionesH-Index: 5
view all 61 authors...
Abstract Background The European Association of Urology (EAU) prognostic factor risk groups for non–muscle-invasive bladder cancer (NMIBC) are used to provide recommendations for patient treatment after transurethral resection of bladder tumor (TURBT). They do not, however, take into account the widely used World Health Organization (WHO) 2004/2016 grading classification and are based on patients treated in the 1980s. Objective To update EAU prognostic factor risk groups using the WHO 1973 and 2...
Source
Abstract Context This review focuses on the most widely used risk stratification and prediction tools for non–muscle-invasive bladder cancer (NMIBC). Objective To assess the clinical use and relevance of risk stratification and prediction tools to enhance clinical decision making and counselling of patients with NMIBC. Evidence acquisition The most frequent, currently used risk stratification tools and prognostic models for NMIBC patients were identified by the members of the European Associatio...
Source
Abstract Background Papillary urothelial neoplasm of low malignant potential (PUN-LMP) was introduced as a noninvasive, noncancerous lesion and a separate grade category in 1998. Subsequently, PUN-LMP was reconfirmed by World Health Organization (WHO) 2004 and WHO 2016 classifications for urothelial bladder tumors. Objectives To analyze the proportion of PUN-LMP diagnosis over time and to determine its prognostic value compared to Ta-LG (low-grade) and Ta-HG (high-grade) carcinomas. To assess th...
Source
#1Anouk E. HentschelH-Index: 5
#2B.W.G. Van RhijnH-Index: 10
Last. Isabel AlemanyH-Index: 3
view all 62 authors...
Source
Abstract Context This overview presents the updated European Association of Urology (EAU) guidelines for non–muscle-invasive bladder cancer (NMIBC), TaT1, and carcinoma in situ (CIS). Objective To provide practical recommendations on the clinical management of NMIBC with a focus on clinical presentation and recommendations. Evidence acquisition A broad and comprehensive scoping exercise covering all areas of the NMIBC guidelines has been performed annually since the last published version in 201...
Source
#1Viktor Soukup (First Faculty of Medicine, Charles University in Prague)H-Index: 17
#2Otakar Čapoun (First Faculty of Medicine, Charles University in Prague)H-Index: 11
Last. Marta Kalousová (First Faculty of Medicine, Charles University in Prague)H-Index: 27
view all 9 authors...
: Aim of the study is to define the diagnostic accuracy of selected urinary protein biomarkers in the non-invasive detection of primary and recurrent urothelial carcinoma of the urinary bladder. The urinary levels of calprotectin, CD147, APOA4 and protein deglycase DJ-1 were examined in 255 individuals, including 60 controls with non-malignant urological disease, 61 patients with a history of urinary bladder cancer with negative cytology and negative cystoscopy and 134 patients with urinary blad...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.